Frequently Asked Questions
The global lithium drug market is growing at a healthy CAGR of 4.30% in the forecast period 2022- 2028.
The countries covered in the lithium drug market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
The major players covered in the lithium drug market are Talison Lithium Limited, Nemaska Lithium Inc., Sociedad Quimica y Minera, Orocobre Limited, Quinghai Lithium, Citic Guoan MGL, SQM Ltd.
Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries.
Rising neurological diseases/disorders such as bipolar disorder, mania, depression and other mental disorder are the factors responsible for the growth of this market.
